Results
1 -
10 of
17Tanaka T; Sugawara H; Maruoka H; Imajo S; Muto T.
Discovery of novel series of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as human chymase inhibitors using structure-based drug design., Bioorganic & medicinal chemistry Gu SJ; Lee JK; Pae AN; Chung HJ; Rhim H; Han SY; Min SJ; Cho YS.
Synthesis and biological evaluation of 1,4-diazepane derivatives as T-type calcium channel blockers., Bioorganic & medicinal chemistry letters Moussa IA; Banister SD; Manoli M; Doddareddy MR; Cui J; Mach RH; Kassiou M.
Exploration of ring size in a series of cyclic vicinal diamines with ?? receptor affinity., Bioorganic & medicinal chemistry letters Zindell R; Walker ER; Scott J; Linehan B; Patel M; Patel M; L?bbe S; Block S; Albrecht C; Gemkow MJ; Shih DT; Riether D; Amouzegh P; Wu L; Ermann M; Thomson D; Fisher MB; Fullenwider CL; Grbic H; Kaplita P.
Aryl 1,4-diazepane compounds as potent and selective CB2 agonists: optimization of drug-like properties and target independent parameters., Bioorganic & medicinal chemistry letters Riether D; Wu L; Cirillo PF; Gemkow MJ; Grbic H; L?bbe S; M?ller C; O'Shea K; Sauer A; Shih DT; Thomson DS; Berry A; Walker ER; Ermann M; Noya-Marino B; Jenkins JE; Albaugh D; Albrecht C; Fisher M.
1,4-Diazepane compounds as potent and selective CB2 agonists: optimization of metabolic stability., Bioorganic & medicinal chemistry letters Coleman PJ; Schreier JD; McGaughey GB; Renger JJ; Bogusky MJ; Cox CD; Hartman GD; Ball RG; Harrell CM; Reiss DR; Prueksaritanont T; Winrow CJ.
Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonists., Bioorganic & medicinal chemistry letters